4.53

3.21% -0.15

G1 Therapeutics Inc (GTHX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché GTHX Giù? Forum Previsione

Precedente Chiudi:

$4.68

Aprire:

$4.68

Volume 24 ore:

590.19K

Capitalizzazione di mercato:

$236.83M

Reddito:

$82.51M

Utile/perdita netta:

$-47.97M

Rapporto P/E:

-2.6805

EPS:

-1.69

Flusso di cassa netto:

$-38.34M

1 W Prestazione:

-5.03%

1M Prestazione:

+5.84%

6M Prestazione:

+188.54%

1 anno Prestazione:

+63.54%

Intervallo 1D:

$4.495

$4.69

Portata 52W:

$1.08

$6.14

G1 Therapeutics Inc Stock (GTHX) Company Profile

Nome

G1 Therapeutics Inc

Settore

Healthcare (1209)

Industria

Biotechnology (699)

Telefono

919-213-9835

Indirizzo

79 T.W. Alexander Drive, Suite 100 4501 Research Commons, Research Triangle Park, NC

Dipendente

Cinguettio

@G1Therapeutics

Prossima data di guadagno

2024-06-13

Ultimi documenti SEC

GTHX's Discussions on Twitter

G1 Therapeutics Inc Stock (GTHX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-01-30	Aggiornamento	JP Morgan	Underweight → Neutral
2023-01-03	Reiterato	Needham	Buy
2021-11-04	Downgrade	JP Morgan	Neutral → Underweight
2021-10-15	Ripresa	BTIG Research	Buy
2021-09-30	Downgrade	JP Morgan	Overweight → Neutral
2020-11-17	Downgrade	Raymond James	Strong Buy → Outperform
2020-06-26	Iniziato	ROTH Capital	Buy
2020-01-21	Reiterato	H.C. Wainwright	Buy
2019-08-08	Aggiornamento	JP Morgan	Neutral → Overweight
2019-02-07	Iniziato	B. Riley FBR	Buy
2019-01-23	Downgrade	JP Morgan	Overweight → Neutral
2018-12-20	Iniziato	Raymond James	Strong Buy
2018-11-08	Reiterato	Needham	Buy
2018-09-10	Ripresa	BTIG Research	Buy
2018-05-29	Iniziato	H.C. Wainwright	Buy
2018-05-18	Reiterato	Needham	Buy

Mostra tutto

G1 Therapeutics Inc Borsa (GTHX) Ultime notizie

Financial Snapshot: Analyzing G1 Therapeutics Inc (GTHX)'s Key Ratio Metrics – DWinneX - The Dwinnex

The Dwinnex

President and CEO Bailey John E. (Jack) Jr. sold 37258 shares of G1 Therapeutics Inc [GTHX] – Knox Daily - Knox Daily

Knox Daily

G1 Therapeutics, Inc. (NASDAQ:GTHX) Sees Significant Increase in Short Interest - MarketBeat

MarketBeat

G1 Therapeutics CFO sells shares worth over $39,000 By Investing.com - Investing.com Australia

Investing.com Australia

G1 Therapeutics executive sells over $39k in stock By Investing.com - Investing.com Canada

Investing.com Canada

G1 Therapeutics CFO sells shares worth over $39,000 By Investing.com - Investing.com Canada

Investing.com Canada

G1 Therapeutics Inc Azioni (GTHX) Dati Finanziari